The Role of Vitamin E Supplements in the Prevention of Cardiovascular Disease and Cancer

Summary

There is insufficient evidence to recommend for or against the use of routine vitamin E supplementation for the primary prevention of CVD events in the general population and in male smokers (I Recommendation).

The Task Force concludes that there is good evidence to recommend against the use of routine vitamin E supplementation for the Alkhenizan & Palda with CTF – Vitamin E Supplements secondary prevention of CVD in patients with established CVD or risk factors for CVD (D Recommendation).

There is good evidence to recommend against the use of routine vitamin E supplementation for the prevention of lung cancer (D Recommendation).

The Task Force concludes that there is insufficient evidence to recommend for or against the use of routine vitamin E supplementation for the prevention of cancers other than lung cancer (esophageal, stomach, colorectal, urological, and prostate) in the general population (I Recommendation).